Hematology and Medical Oncology, Boston University School of Medicine, Boston, Massachusetts.
Department of Medicine, University of California, San Francisco.
JAMA Netw Open. 2021 May 3;4(5):e2112558. doi: 10.1001/jamanetworkopen.2021.12558.
This cross-sectional study of all hematology/oncology drugs approved by the US Food and Drug Administration in 2020 assesses the functioning of the drug approval process following disruptions related to the COVID-19 pandemic.
本研究对 2020 年美国食品和药物管理局批准的所有血液学/肿瘤学药物进行了横断面研究,评估了与 COVID-19 大流行相关的中断后药物批准流程的运行情况。